David S. Blatteis is a member of the firm’s Management Committee and Co-Chair of its Business Law
Group. He concentrates his practice in the areas of business law, pharmaceutical, medical device, and
healthcare.
David understands the unique business and complex legal concerns of pharmaceutical companies and
service providers in the pharmaceutical industry.
He represents pharmaceutical manufacturers, medical device companies, healthcare service
organizations, and molecular diagnostic companies in connection with a wide range of commercial
transactions including mergers and acquisitions, corporate partnerships, joint ventures, and other
strategic alliances. His clients manufacture, market, promote, advertise, and sell pharmaceutical
products, and provide technology, regulatory and compliance, and promotional solutions to the
healthcare industry. For these clients, he drafts and negotiates manufacturing, supply and development,
license, distribution, co-promote and risk-share agreements, customer and vendor contracts, as well as
major outsourced sales team, promotional, media, advertising, technology, and service arrangements.
David’s clients benefit from his extensive experience negotiating agreements, his understanding of a
complex healthcare compliance and regulatory environment, and his years of experience working with
in-house counsel to accomplish their goals. By developing a meaningful relationship with his clients and
understanding their business environments and needs, David takes pride in helping them accomplish
their goals in an efficient and effective manner.
David also serves as general counsel to a market-leading orthopedic device company. He has a wide
range of experience providing general business advice, litigation management, and employment
counseling for his clients, enabling him to serve as a trusted advisor.
Areas of Practice:
- Business Law
- Mergers and Acquisitions
- Health Care & Life Sciences
- Pharmaceutical/Medical Devices/Pharma Services
